To identify inhibitors of interleukin-8 (IL-8) production, a high throughput assay was developed using the Quanti-Gene™ nucleic acid quantification kit that employs branched-chain DNA (bDNA) technology to measure the mRNA directly from cells. Unlike polymerase chain reaction and other technologies that employ target amplification, the QuantiGene system uses signal amplification. To perform the assay, various molecular probes capable of hybridizing with IL-8 mRNA were designed and synthesized. A human lung epithelial cell line was treated with interleukin-la (IL-la) to stimulate the IL-8 gene expression and the mRNA was measured using the QuantiGene system. The QuantiGene assay was sensitive, flexible, and reproducible and achieved equivalent or better sensitivity than promoter-reporter assays, and eliminated the time required for constructing a promoter-reporter system. Our data show that bDNA technology has the potential to be used as a high throughput screening assay.
References
1.
Chaudhary, L.R., Spelsberg, T.C., Riggs, B.L. (1992). Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha Lack of regulation by 17 beta-estradiol. Endocrinoiogx130:2528-2534,
2.
Baggiolini, M., Clark-Lewis, I. (1992). Interleukin-8. a chemnotactic and inflammatory cytokine. FEBS Lett.307:97-101
3.
Miller, M.D., Krangel, M.S. (1992). Biology and biochemistry of the chemokines: A family of chemotactic and inflammaton,,w cytokines. Crit. Rev. Immunol.12:17-46.
4.
Oppenheim, J.J., Zachariae, C.O., Mukaida, N., Matsushima, K. (1991). Properties of the novel proinflammatory supergene "intercrine" cytokine family. Anou. Rev. Immunol.9:617-648.
5.
Matsushima, K., Baldwin, E.T., Mukaida, N. (1992). Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines. Chem. Immunol.51:236-265.
6.
Mukaida, N., Harda, A., Yasumoto, K., Matsushima, K. (1992). Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microb. Immunol.36:773-789.
7.
Peichl, P., Ceska, M., Effenberger, F., Haberhauer, G., Broell, H.Lindley, J.J. (1991). Presence of NAP-/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Sctand. J. Immunol.34:333-339.
8.
Brennan, F.M., Zachariae, C.O., Chantry, D., Larsen, C.G., Turner, M., Maini, R.N., Matsushima, K., Feldmann, M. (1990). Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur. J. Immunol.20:2141-2144.
9.
Schutte, H., Lohmeyer, J., Rosseau, S., Ziegler, S., Siebert, C., Kielisch, H., Pralle, H., Grimminger, F., Morr, H., Seeger, W. (1996). Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur. Respir. J.9:1858-1867.
10.
Richman-Eisenstat, J.B., Jorens, P.G., Hebert, C.A., Ueki, I., Nadel, J.A. (1993). Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am. J. Physiol.264(4 Pt 1):L413-L418.
11.
Jones, S.C., Evans, S.W., Lobo, A.J., Ceska, M., Axon, A.T., Whicher, J.T. (1993). Serum interleukin-8 in inflammatory bowel disease. J. Gastroenterol. Hepatol.8:508-512.
12.
Sticherling, M., Sautier, W., Schroder, J.M., Christophers, E. (1999). Interleukin-8 plays its role at local level in psoriasis vulgaris. Acta Derm Venereol.79:4-8.
13.
Lee, J., Horuk, R., Rice, G.C., Bennett, G.L., Camerato, T., Wood, W.I. (1992). Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem.267:16283-16287.
14.
Davis, G.L., Lau, J.Y., Ureda, M.S., Neuwald, P.D., Wilber, J.C., Lindsay, K., Perrillo, R.P., Albrecht, J. (1994). Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology19:1337-1341.
15.
Zaaijer, H.L., ter Borg, F., Cuypers, H.T.M., Hermus, M.C.A.H., Lelie, P.N. (1994). Comparison of methods for detection of hepatitis B virus DNA. J. Clin. Microbiol.32:2088-2091.
16.
Mellors, J.W., Rinaldo, C.R.J., Gupta, P., White, R.M., Todd, J.A., Kingsley, L.A. (1996). Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science272:1167-1170.
17.
Sheets, M.P., Warrior, U., Yoon, H., Mollison, K.W., Djuric, S.W., Trevillyan, J.M. (1998). A high-capacity scintillation proximity assay for the discovery and evaluation of ZAP-70 tandem SH2 domain antagonists. J. Biomol. Screen.3:139.
